Direct evidence for leptin-induced lipid oxidation independent of long-form leptin receptor

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 10, 2010, Pages 1115-1122

  Akasaka, Yunike ^a   Tsunoda, Masaki ^a   Ogata, Tomomi ^a   Ide, Tomohiro ^a   Murakami, Koji ^a  

^a KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Db db mouse; Leptin; P38 MAPK siRNA; Primary myotube; STAT3 siRNA

Indexed keywords

JANUS KINASE 2; LEPTIN; LEPTIN RECEPTOR; PALMITIC ACID; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG INHIBITION; LIPID OXIDATION; MALE; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; ENZYME ACTIVATION; FATTY ACIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; JANUS KINASE 2; LEPTIN; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MUSCLE CELLS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN KINASE INHIBITORS; RECEPTORS, LEPTIN; STAT3 TRANSCRIPTION FACTOR;

MURINAE; MUS;

EID: 77955514503     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.06.009     Document Type: Article

References (44)

1. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
2. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543.
3. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
4. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
5. Wang J.L., Chinookoswong N., Scully S., Qi M., Shi Z.Q. Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology 1999, 140:2117-2124.
6. Harris R.B., Zhou J., Redmann S.M., Smagin G.N., Smith S.R., Rodgers E., Zachwieja J.J. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 1998, 139:8-19.
7. Kastin A.J., Pan W., Maness L.M., Koletsky R.J., Ernsberger P. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 1999, 20:1449-1453.
8. Hileman S.M., Pierroz D.D., Masuzaki H., Bjørbaek C., El-Haschimi K., Banks W.A., Flier J.S. Characterization of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 2002, 143:775-783.
9. Merino B., Díez-Fernández C., Ruiz-Gayo M., Somoza B. Choroid plexus epithelial cells co-express the long and short form of the leptin receptor. Neurosci. Lett. 2006, 393:269-272.
10. Uotani S., Bjørbaek C., Tornøe J., Flier J.S. Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation. Diabetes 1999, 48:279-286.
11. Cui H., Cai F., Belsham D.D. Leptin signaling in neurotensin neurons involves STAT, MAP kinases ERK1/2, and p38 through c-Fos and ATF1. FASEB J. 2006, 20:2654-2656.
12. Solinas G., Summermatter S., Mainieri D., Gubler M., Pirola L., Wymann M.P., Rusconi S., Montani J.P., Seydoux J., Dulloo A.G. The direct effect of leptin on skeletal muscle thermogenesis is mediated by substrate cycling between de novo lipogenesis and lipid oxidation. FEBS Lett. 2004, 577:539-544.
13. Maroni P., Bendinelli P., Piccoletti R. Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol. Cell. Endocrinol. 2003, 201:109-121.
14. Bahrenberg G., Behrmann I., Barthel A., Hekerman P., Heinrich P.C., Joost H.G., Becker W. Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers. Mol. Endocrinol. 2002, 16:859-872.
15. Bjorbaek C., Uotani S., da Silva B., Flier J.S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 1997, 272:32686-32695.
16. Ghilardi N., Skoda R.C. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol. 1997, 11:393-399.
17. Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Muller C., Carling D., Kahn B.B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002, 415:339-343.
18. Atkinson L.L., Fischer M.A., Lopaschuk G.D. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J. Biol. Chem. 2002, 277:29424-29430.
19. Akasaka Y., Tsunoda M., Ide T., Murakami K. Chronic leptin treatment stimulates lipid oxidation in immortalized and primary mouse skeletal muscle cells. Biochim. Biophys. Acta 2009, 1791:103-109.
20. Tesseraux I., Gulden M., Wassermann O. Cultured myotubes from skeletal muscle of adult rats. Characterization and action of Anemonia sulcata toxin II. Naunyn Schmiedebergs Arch. Pharmacol. 1987, 336:232-239.
21. Murakami K., Tobe K., Ide T., Mochizuki T., Ohashi M., Akanuma Y., Yazaki Y., Kadowaki T. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Diabetes 1998, 47:1841-1847.
22. Tan B.K., Chen J., Brown J., Adya R., Ramanjaneya M., Menon V., Bailey C.J., Lehnert H., Randeva H.S. In vivo and ex vivo regulation of visfatin production by leptin in human and murine adipose tissue: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Endocrinology 2009, 150:3530-3539.
23. Maedler K., Schulthess F.T., Bielman C., Berney T., Bonny C., Prentki M., Donath M.Y., Roduit R. Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB J. 2008, 22:1905-1913.
24. Lee G.H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., Friedman J.M. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996, 379:632-635.
25. Fruhbeck G., Gomez-Ambrosi J., Martinez J.A. Pre- and postprandial expression of the leptin receptor splice variants OB-Ra and OB-Rb in murine peripheral tissues. Physiol. Res. 1999, 48:189-195.
26. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., Skoda R.C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl Acad. Sci. USA 1996, 93:6231-6235.
27. Jiang L., You J., Yu X., Gonzalez L., Yu Y., Wang Q., Yang G., Li W., Li C., Liu Y. Tyrosine-dependent and -independent actions of leptin receptor in control of energy balance and glucose homeostasis. Proc. Natl Acad. Sci. USA 2008, 105:18619-18624.
28. Harris R.B., Mitchell T.D., Yan X., Simpson J.S., Redmann S.M. Metabolic responses to leptin in obese db/db mice are strain dependent. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:R115-R132.
29. Osborn O., Sanchez-Alavez M., Brownell S.E., Ross B., Klaus J., Dubins J., Beutler B., Conti B., Bartfai T. Metabolic characterization of a mouse deficient in all known leptin receptor isoforms. Cell. Mol. Neurobiol. 2010, 30:23-33.
30. Ben-Eliezer M., Phillip M., Gat-Yablonski G. Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways. Endocr. 2007, 32:235-244.
31. Chung J., Uchida E., Grammer T.C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 1997, 17:6508-6516.
32. Lim C.P., Cao X. Serine phosphorylation and negative regulation of Stat3 by JNK. J. Biol. Chem. 1999, 274:31055-31061.
33. Xu B., Bhattacharjee A., Roy B., Xu H.M., Anthony D., Frank D.A., Feldman G.M., Cathcart M.K. Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3. Mol. Cell. Biol. 2003, 23:3918-3928.
34. Ng D.C., Long C.S., Bogoyevitch M.A. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal transducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology. J. Biol. Chem. 2001, 276:29490-29498.
35. Rajapurohitam V., Gan X.T., Kirshenbaum L.A., Karmazyn M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ. Res. 2003, 93:277-279.
36. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.
37. Berti L., Gammeltoft S. Leptin stimulates glucose uptake in C2C12 muscle cells by activation of ERK2. Mol. Cell. Endocrinol. 1999, 157:121-130.
38. Yoon M.J., Lee G.Y., Chung J.J., Ahn Y.H., Hong S.H., Kim J.B. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 2006, 55:2562-2570.
39. Robidoux J., Cao W., Quan H., Daniel K.W., Moukdar F., Bai X., Floering L.M., Collins S. Selective activation of mitogen-activated protein (MAP) kinase kinase 3 and p38alpha MAP kinase is essential for cyclic AMP-dependent UCP1 expression in adipocytes. Mol. Cell. Biol. 2005, 25:5466-5479.
40. Cao Q., Mak K.M., Ren C., Lieber C.S. Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK/STAT and JAK-mediated H2O2-dependant MAPK pathways. J. Biol. Chem. 2004, 279:4292-4304.
41. Crunkhorn S., Dearie F., Mantzoros C., Gami H., da Silva W.S., Espinoza D., Faucette R., Barry K., Bianco A.C., Patti M.E. Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 2007, 282:15439-15450.
42. Collins Q.F., Xiong Y., Lupo E.G., Liu H.Y., Cao W. p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes. J. Biol. Chem. 2006, 281:24336-24344.
43. Xiong Y., Collins Q.F., An J., Lupo E., Liu H.Y., Liu D., Robidoux J., Liu Z., Cao W. p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis. J. Biol. Chem. 2007, 282:4975-4982.
44. Sharma V., Mustafa S., Patel N., Wambolt R., Allard M.F., McNeill J.H. Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism. Eur. J. Pharmacol. 2009, 617:113-117.